Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1973;48:1194-1200

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STEELE, P. P.
Right arrow Articles by GENTON, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STEELE, P. P.
Right arrow Articles by GENTON, E.

(Circulation. 1973;48:1194.)
© 1973 American Heart Association, Inc.


Platelet Function Studies in Coronary Artery Disease

PETER P. STEELE M.D.1; HUGH S. WEILY M.D.1; HYWEL DAVIES M.D.1; EDWARD GENTON M.D.1

1 From the Division of Cardiology, Department of Medicine, Denver Veterans Administration Hospital and the University of Colorado Medical Center, Denver, Colorado.

Platelets have been implicated and abnormal platelet function proposed in the pathogenesis of coronary artery disease (CAD). This investigation examines platelet function in men with stable, arteriographically defined CAD and correlates results with lipid pattern, history of angina or myocardial infarction and smoking habits. Platelet survival (51Chromium method), adhesiveness, and aggregation were measured in 21 men with CAD. Twelve patients had Type IV hyperlipoproteinemia and nine patients had normal lipoprotein level. Eighteen had angina and 13 had had infarction.

The average platelet survival for the total group was normal (6.8 ± 0.24 days, avg ± sem), but survival was shortened in 11 and normal in ten. There was no significant difference between: (1) patients with hyperlipoproteinemia (6.8 ± 0.30 days) and those with normal lipoproteins (6.9 ± 0.41 days); (2) patients with angina (6.8 ± 0.28 days) and without (6.6 ± 0.26 days); (3) patients with infarction (6.8 ± 0.26 days); and without (6.8 ± 0.50 days); (4) patients with varying patterns of arteriographic involvement; and (5) with varying smoking histories. Adhesiveness was normal in all. Aggregation was normal in 14. Neither adhesiveness nor aggregation correlated with platelet survival or defined the subgroups of CAD. Results suggest an abnormal short platelet survival frequently occurs in patients with CAD, but there is no discernible difference in platelet survival among the various clinical subgroups of CAD.


Key Words: Thrombosis • Atherosclerosis • Hyperlipoproteinemia • Myocardial infarction • Angina • Cigarette smoking

Submitted on May 2, 1973
Accepted on July 25, 1973




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. J. Knight, M. Panesar, C. Wright, D. Clarke, P. S. Butowski, D. Patel, A. Patrineli, K. Fox, and A. H. Goodall
Altered Platelet Function Detected by Flow Cytometry : Effects of Coronary Artery Disease and Age
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2044 - 2053.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
J. T. Willerson and J. T. Willerson
Peripheral Venous Platelet Aggregates in Patients With Unstable Angina Pectoris and Acute Myocardial Infarction
Angiology, October 1, 1977; 28(10): 695 - 701.
[Abstract] [PDF]